BUND FINANCE › Stocks › IQV
IQVIA Holdings Inc. (IQV)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:01 PM New York time · may be delayed
Key stats
Quick technical read
- Price is -3.55% below its 50-day average.
- It is +22.01% above its 200-day average (long-term uptrend).
- It sits at 79% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | US$13.9B | US$14.4B | US$15.0B | US$15.4B | US$16.3B |
| Net income | US$966.0M | US$1.1B | US$1.4B | US$1.4B | US$1.4B |
| EPS (diluted) | 4.95 | 5.72 | 7.29 | 7.49 | 7.84 |
| Gross margin | 33.5% | 34.9% | 35.0% | 34.9% | 33.3% |
| Operating margin | 10.0% | 12.5% | 13.2% | 14.3% | 13.4% |
| Net margin | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| Free cash flow | US$2.3B | US$1.6B | US$1.5B | US$2.1B | US$2.1B |
| Total debt | US$12.4B | US$13.0B | US$13.9B | US$14.2B | US$16.2B |
| Cash | US$1.4B | US$1.2B | US$1.4B | US$1.7B | US$2.0B |
Compound annual growth: revenue 4.1% · net income 8.9% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 31.3x | 35.4x | 27.1x |
| EV / EBITDA | 15.7x | 17.9x | 16.5x |
| Operating margin | 13.4% | — | 3.6% |
| Net margin | 8.1% | — | -0.0% |
| Debt / equity | 3.56 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence …
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice